Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?

The emergence of COVID-19 has created a major health crisis across the globe. Invasion of SARS-CoV-2 into the lungs causes acute respiratory distress syndrome (ARDS) that result in the damage of lung alveolar epithelial cells. Currently, there is no standard treatment available to treat the disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Warrier, Sudha, Mohana Sundaram, S, Varier, Lavanya, Balasubramanian, Ananthakrishnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647345/
https://www.ncbi.nlm.nih.gov/pubmed/34915433
http://dx.doi.org/10.1016/j.placenta.2021.12.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647345/
https://www.ncbi.nlm.nih.gov/pubmed/34915433
http://dx.doi.org/10.1016/j.placenta.2021.12.005

Ejemplares similares